- The spin-off of the University of Granada Rekom Biotech designs recombinant antigens useful for the identification of these two viral diseases, which affect millions of people worldwide.
Researchers at the University of Granada have designed a set of biomarkers that can be used in diagnostic tests for the detection of dengue and the West Nile virus, two infectious diseases transmitted by the bite of a mosquito. These biomarkers can be used to identify these viral diseases, which affect millions of people worldwide.
The University of Granada spin-off Rekom Biotech is a biotech company composed of professionals from the private sector and from the University of Granada. Rekom Biotech is focused in the design and production of biological material used in diagnostic tests called “recombinant antigents”. These antigens are markers of a variety of diseases caused by viruses, bacteria, fungi and parasites.
Saving Lives and Money
These products can be used in the different in vitro diagnostic platforms or systems. Specifically, the biomarkers designed at the University of Granada spin off “might serve to design diagnostic tests that will help save lives and money”, states the Rekom Biotech general manager, Ana Camacho Páez.
The Andalusian company also supplies other services based on the design and production of proteins and other molecular biology tools.
Currently, Rekom Biotech supplies white label recombinant antigens to two American companies, and will start supplying biological material to a German company soon. Their catalogue includes more than 50 recombinant antigens for the in vitro diagnosis of a range of infectious diseases. This company conducts its R&D activities at the Health Technology Park in Granada, Spain.
1. Part of the team of the ‘spin-off’ Rekom Biotech. From left to right, Pilar Bordetas, María José Barroso, Ana Camacho and Isaac González.
2. Electrophoresis of DNA observed under ultraviolet light.
3. A technician at Rekom Biotech uses the chromatogram for the purification of a biomarker.
Contacting person:
Ana Camacho Páez
Rekom Biotech General Manager
Phone number:+34 958 63 70 85 / 607 861 573
Web site: http://www.rekombiotech.com/es
E-mail address: agcamacho@rekombiotech.com
